The Leadership Team at Sygnature Discovery Limited drives the strategic vision and operational excellence of the company, overseeing pivotal drug discovery initiatives across various therapeutic areas. Comprising experts in oncology, immunology, inflammation, and neuroscience, as well as key roles in finance, operations, and human resources, this team fosters collaboration and innovation to enhance the company's capabilities in drug development and ensure alignment with its mission to deliver effective solutions for clients.
Allan Jordan
VP, Oncology Drug Discovery
James Edgar
Chief People Officer
John Unitt
VP, Immunology & Inflammation ...
Jonathan Williams
COO & Director
Louisa Jordison
CFO & Director
Max Mirza
VP, Neuroscience Drug Discover...
Paul Overton
CCO & Director
Simon Hirst
Founder, CEO & Director
Stephen Young
VP, Hit ID Technologies
Stuart Onions
CTO
View all